Pan-Asia Index Rebalances/ Events/ Delta One, Periscope Analytics

Brian Freitas

Highly experienced ex-Delta One trader with 17 years of experience trading arbitrage and related strategies across Asian markets.

Exempt Financial Adviser (EFA) under CrossASEAN Research Pte Ltd.

It is important to note that the information provided by Periscope Analytics is based on publicly available data and own knowledge, which has been gathered and synthesized from a variety of sources. While every effort has been made to ensure the accuracy and completeness of the information provided, it is not guaranteed to be free from errors or omissions.

All forecasts and estimates are based on information that has been obtained from public sources that are considered to be reliable. The sources include, but are not limited to, company announcements, exchange filings, ETF and other passive investment vehicle holdings, and free float and volume data from third-party data providers. Periscope Analytics does not guarantee the accuracy and completeness of the forecasts, estimates and/or other information.

Pan-Asia Index Rebalances/ Events/ Delta One

SK Bioscience K200 Entry: Potential Trades Reflecting SK Biopharm's Passive Inflow Pattern

SK BioS Lockup Release Today: FO Drop Can Signal a Tight Supply for Passive Mirroring K200

Why NPS Buys SK Bioscience Lately & Lurking Timing for KOSPI 200 Entry Event

SK IE Technology IPO: Fast Index Entry Possibilities

SK Bioscience IPO: KOSPI200 Inclusion Certain; MSCI/FTSE Is a No Go; Watch SK Chem

SK Bioscience IPO: Fast Index Entry Possibilities

Event-Driven

<a href="https://www.smartkarma.com/entities/sk-bioscience-co-ltd" target="_blank" data-smartkarma-citation="entities:31484:1" rel="noopener">SK Bioscience (302440 KS)</a> is a biopharmaceutical company that focuses on the discovery and production of vaccines. The company was spun off from <a href="https://www.smartkarma.com/entities/sk-chemicals-co-ltd-new" target="_blank" data-smartkarma-citation="entities:26190:1" rel="noopener">Sk Chemicals Co Ltd/New (285130 KS)</a> in 2018 and is now 68.65% owned by SK Chemicals.The company issued stock at KRW 65,000/share in the IPO and the stock closed limit up at KRW 169,000 on listing day. Since then, the stock has dropped 30% and is trading at the lows since listing. The stock has been stable over the last few days as volumes taper off and a lot of flippers have likely exited the stock.With 2 days to go in the 15 day period that is used to determine Fast Entry for new listings in the <a href="https://www.smartkarma.com/entities/korea-stock-exchange-kospi-200-index" target="_blank" data-smartkarma-citation="entities:26021:1" rel="noopener">Korea Stock Exchange Kospi 200 Index (KOSPI2 INDEX)</a>, we take a look at the probability of the stock getting Fast Entry into the index, the lock up expiry schedule and the impact of passive buying on the stock.If included in the index, passive trackers will need to buy over 4% of the free floating <a href="https://www.smartkarma.com/entities/sk-bioscience-co-ltd" target="_blank" data-smartkarma-citation="entities:31484:1" rel="noopener">SK Bioscience (302440 KS)</a> stock as of the implementation date. We see <a href="https://www.smartkarma.com/entities/sebang-global-battery-co-ltd" target="_blank" data-smartkarma-citation="entities:9618:1" rel="noopener">Sebang Global Battery (004490 KS)</a> as the most likely deletion to make way for SK Bioscience in the index.

SK Bioscience (302440 KS) is a biopharmaceutical company that focuses on the discovery and production of vaccines. The company was spun off from Sk Chemicals Co Ltd/New (285130 KS) in 2018 and is now 68.65% owned by SK Chemicals.The company issued stock at KRW 65,000/share in the IPO and the stock closed limit up at KRW 169,000 on listing day. Since then, the stock has dropped 30% and is trading at the lows since listing. The stock has been stable over the last few days as volumes taper off and a lot of flippers have likely exited the stock.With 2 days to go in the 15 day period that is used to determine Fast Entry for new listings in the Korea Stock Exchange Kospi 200 Index (KOSPI2 INDEX), we take a look at the probability of the stock getting Fast Entry into the index, the lock up expiry schedule and the impact of passive buying on the stock.If included in the index, passive trackers will need to buy over 4% of the free floating SK Bioscience (302440 KS) stock as of the implementation date. We see Sebang Global Battery (004490 KS) as the most likely deletion to make way for SK Bioscience in the index.

Korea Stock Exchange KOSPI 200 (KOSPI2 INDEX EQUITY)

SK Bioscience IPO: KOSPI200 Fast Entry Guaranteed; SGBC Most Likely Deletion